Alexander Y Walley
Overview
Explore the profile of Alexander Y Walley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
226
Citations
4673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCann N, Yan S, McMahan V, Pope E, Rolles A, Brennan S, et al.
J Addict Med
. 2025 Feb;
PMID: 39908533
Background: Calendar-based timeline follow-back (TLFB) instruments have been used to assess alcohol use, smoking, and other behaviors. We assessed test-retest reliability of an adapted TLFB addressing opioid-related outcomes over 120...
2.
Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, et al.
Harm Reduct J
. 2025 Jan;
22(1):11.
PMID: 39849487
Background: The City of Boston has faced unprecedented challenges with substance use amidst changes to the illicit drug supply and increased visibility of homelessness. Among its responses, Boston developed six...
3.
Reed G, Lugo H, Adams R, Walley A
Addict Sci Clin Pract
. 2024 Dec;
19(1):94.
PMID: 39696642
Background: Traumatic brain injury (TBI) is common in people with substance use disorders (SUDs). TBI often results in cognitive deficits which can affect the clinical course of SUD. Case Presentation:...
4.
Barocas J, Erdman E, Westfall M, Christine P, Bernson D, Villani J, et al.
Addiction
. 2024 Dec;
120(4):711-720.
PMID: 39676746
Background And Aims: Stimulant-involved overdose deaths are increasing throughout the United States. Because stimulant misuse (i.e. taking a prescribed medicine not as directed) and stimulant use disorder contribute to the...
5.
Rosenmoss S, Larochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, et al.
J Addict Med
. 2024 Nov;
19(2):165-171.
PMID: 39514897
Objectives: The aim of the study was to examine the association between Black, White, and Hispanic or Latino race and ethnicity and referral rejection from private postacute care facilities among...
6.
Cummins E, Walley A, Xuan Z, Yan S, Schoenberger S, Formica S, et al.
Addiction
. 2024 Oct;
120(2):327-334.
PMID: 39467382
Background And Aims: Involuntary civil commitment (ICC) is a legal process by which people are compulsorily admitted to substance use treatment. This study explored views about and promotion of ICC...
7.
Zang X, Skinner A, Li Z, Shaw L, Behrends C, Chatterjee A, et al.
Addiction
. 2024 Oct;
120(2):316-326.
PMID: 39450522
Background And Aims: During the COVID-19 pandemic, there was a surge in opioid overdose deaths (OODs) in Massachusetts, USA, particularly among Black and Hispanic/Latinx populations. Despite the increasing racial and...
8.
Freisthler B, Chahine R, Villani J, Chandler R, Feaster D, Slavova S, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2440006.
PMID: 39432308
Importance: The HEALing Communities Study (HCS) evaluated the effectiveness of the Communities That HEAL (CTH) intervention in preventing fatal overdoses amidst the US opioid epidemic. Objective: To evaluate the impact...
9.
Freeman P, Walley A, Winhusen T, Oga E, Villani J, Hunt T, et al.
Am J Public Health
. 2024 Oct;
115(1):83-94.
PMID: 39388670
To determine whether the Communities That HEAL (CTH) intervention is effective in increasing naloxone distribution compared with usual care. The HEALing (Helping to End Addiction Long-Term) Communities Study (HCS) is...
10.
Russell E, Hawk M, Neale J, Bennett A, Davis C, Hill L, et al.
Int J Drug Policy
. 2024 Sep;
133:104587.
PMID: 39299143
High dose and long-acting opioid overdose reversal drugs can precipitate withdrawal in people who are opioid dependent. Products recently brought to market for community use in the United States (US)...